Celldex (CLDX) Tops Q3 EPS by 3c
Tweet
Share
E-mail
Get Alerts CLDX Hot Sheet
Join SI Premium – FREE
Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.64), $0.03 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $3.19 million versus the consensus estimate of $835.56 thousand.
For earnings history and earnings-related data on Celldex (CLDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
- Kyverna Therapeutics names Ritesh Srivastava as chief legal officer
- Centuri reports $360M+ in new contract awards, including data center
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
